TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
Lei Gao(Fujian Medical University), Dongying Zhang(Huaian First People’s Hospital), Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Linna You(The Affiliated Yongchuan Hospital of Chongqing Medical University), Hongmei Tao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dan Jiang(Wenzhou Medical University), Liyou Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guanglei Chang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shu Qin(The Affiliated Yongchuan Hospital of Chongqing Medical University), Min Sun(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shiyong Wu(National Health and Family Planning Commission), Yuqian Guo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhiqiang Liu(Hebei North University), Jun-shi Xie(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 93
Related Papers
Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307
Convergence and divergence of bitterness biosynthesis and regulation in Cucurbitaceae
|Nature Plants|2016|260
Highly Selective Phosphorescent Chemosensor for Fluoride Based on an Iridium(III) Complex Containing Arylborane Units
|Inorganic Chemistry|2008|229
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
|Journal of Molecular Medicine|2018|106